Navigation Links
HA&W Obtains Approximately $2 M in Credits and Cash Grants for Clients Through the Therapeutic Discovery Project Program

ATLANTA, Nov. 18, 2010 /PRNewswire/ -- Habif, Arogeti & Wynne (HA&W) is pleased to announce that it obtained approximately $2 million in credits and cash grants for qualified clients through the Therapeutic Discovery Project Program (TDPP).  The TDPP was created by the Patient Protection and Affordable Care Act in March 2010 with $1 billion allocated for credits and grants to qualifying projects in increments of up to $5 million.  One hundred percent of HA&W clients who received assistance in applying for grants received an award.

Awards were granted primarily to pharmaceutical companies working on qualified therapeutic drugs that met specific federal healthcare and economic guidelines.

Soon after the passage of this Act, HA&W moved quickly to identify clients who met the complicated eligibility requirements.  This process was made easier due the Firm's Technology & Life Sciences Practice and its well-established R&D practice area.  Based on these relationships, HA&W's staff qualified candidates and worked closely with them to explain the requirements in detail.  As a result, all clients for whom HA&W prepared an application were awarded cash grants or tax credits.

HA&W Partner and Technology & Life Science Practice leader, Mitchell Kopelman, said, "We knew we had a limited window of opportunity to help our clients take advantage of this program.  Our expertise in the R&D tax credits and our close relationships with our clients allowed us to quickly identify those with the best chances and help them with the application process.  I'm proud of our staff and their effort, and I'm very happy for our clients."

In total, 5,600 companies applied for the award by the deadline in July.  A total of 4,606 projects from 2,923 companies were deemed eligible for the award and the recipients were contacted on October 29th.  Fifty-one of the companies are in Georgia.  While the maximum award allowed was $5 million per applicant, the IRS capped the award at $244,479 per project due to the overwhelming number of applicants.

Habif, Arogeti & Wynne, LLP is the largest independent accounting and business advisory firm headquartered in Georgia and one of the top 50 firms in the United States. The firm's more than 300 professionals provide financial solutions – including accounting, auditing and tax services, forensic and litigation services, management consulting, financial planning, technology consulting and financial staffing – to more than 5,000 clients in a variety of industries. HA&W serves its expanding list of international clients through its membership in Baker Tilly International, an association of leading independent accounting firms worldwide. For more information on HA&W, visit

SOURCE Habif, Arogeti & Wynne, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Sky One Medical Obtains SFDA Approval for Ciclopirox Olamine Vaginal Suppositories
2. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
3. Par Obtains Exclusive Rights to Market and Distribute Generic Zetia(R) in the U.S.
4. Sanofi-aventis Obtains Antitrust Clearance in Connection With Chattem, Inc. Tender Offer
5. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
6. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
7. Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
8. Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections
9. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
10. Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government
11. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
Post Your Comments:
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology:
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):